Does Dr. JAMIL ABOUELHOSSEN have financial conflicts of interest?

Dr. JAMIL ABOUELHOSSEN (MD) has received a total of $7,794 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $7,794 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JAMIL ABOUELHOSSEN?

According to CMS Open Payments data, Dr. JAMIL ABOUELHOSSEN received funding from ASTRAZENECA PHARMACEUTICALS ($1,761), BOEHRINGER INGELHEIM PHARMACEUTICALS ($969), and JANSSEN PHARMACEUTICALS ($766).

Does Dr. JAMIL ABOUELHOSSEN receive research grants or speaking fees?

Dr. JAMIL ABOUELHOSSEN has received $7,794 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JAMIL ABOUELHOSSEN

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: FAJARDO, PR 00738

NPI Number: 1356347538

LIFETIME INDUSTRY VALUE

$7,794

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABOUELHOSSEN is a verified Internal Medicine practitioner based in FAJARDO, PR.

Between 2021 and 2025, Dr. ABOUELHOSSEN had an overall industry promotional and research financial footprint of $7,794 as recorded in the federal CMS Open Payments database.

$7,794 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOUELHOSSEN's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $1,761 (representing 22.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$1,761

22.6%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 2

$969

12.4%

JANSSEN PHARMACEUTICALS

Rank 3

$766

9.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.